Anhui Huaheng Biotechnology Co., Ltd.

SHSE:688639 Rapport sur les actions

Capitalisation boursière : CN¥8.3b

Anhui Huaheng Biotechnology Croissance future

Future contrôle des critères 6/6

Anhui Huaheng Biotechnology devrait augmenter ses bénéfices et son chiffre d'affaires de 53.4% et de 37.9% par an respectivement. Le BPA devrait croître de de 53.7% par an. Le rendement des capitaux propres devrait être 25.1% dans 3 ans.

Informations clés

53.4%

Taux de croissance des bénéfices

53.7%

Taux de croissance du BPA

Chemicals croissance des bénéfices39.3%
Taux de croissance des recettes37.9%
Rendement futur des capitaux propres25.1%
Couverture par les analystes

Good

Dernière mise à jour30 Oct 2024

Mises à jour récentes de la croissance future

Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%

Apr 23
Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%

Recent updates

Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward

Oct 21
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward

Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching

Oct 14
Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching

Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch

Sep 05
Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch

Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues

Sep 03
Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues

Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially

Sep 02
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially

Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital

Aug 20
Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital

Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jul 22
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price

Jul 12
Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price

Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?

Jun 21
Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?

Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper

Jun 05
Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper

We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease

May 12
We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease

Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%

Apr 23
Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%

Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't

Mar 18
Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't

Prévisions de croissance des bénéfices et des revenus

SHSE:688639 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20264,8389055589516
12/31/20253,6246774038797
12/31/20242,336244-256-184
9/30/20242,113299-94036N/A
6/30/20242,105408-1,102125N/A
3/31/20242,046443-1,067251N/A
12/31/20231,938449-968301N/A
9/30/20231,799423-664480N/A
6/30/20231,640382-328451N/A
3/31/20231,548346-200381N/A
12/31/20221,419320-99357N/A
9/30/20221,3172838263N/A
6/30/20221,203235-54151N/A
3/31/20221,059192-43170N/A
12/31/2021954168-8596N/A
9/30/2021748138-76111N/A
6/30/2021608118-4161N/A
3/31/2021523120874N/A
12/31/202048712137110N/A
12/31/2019491126100181N/A
12/31/2018421762689N/A
12/31/201738365N/A106N/A
6/30/201736772N/A111N/A
3/31/201733967N/A83N/A
12/31/201631162N/A55N/A
9/30/201628251N/A41N/A
6/30/201625340N/A26N/A
3/31/201625341N/A31N/A
12/31/201525343N/A35N/A
9/30/201524934N/A28N/A
6/30/201524441N/A35N/A
3/31/201523540N/A39N/A
12/31/201422523N/A31N/A
9/30/201421627N/A33N/A
6/30/201420730N/A35N/A
3/31/201419022N/A38N/A
12/31/201317313N/A41N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 688639 ( 53.4% par an) est supérieure au taux d'épargne ( 2.8% ).

Bénéfices vs marché: Les bénéfices de 688639 ( 53.4% par an) devraient croître plus rapidement que le marché CN ( 26.3% par an).

Croissance élevée des bénéfices: Les bénéfices de 688639 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 688639 ( 37.9% par an) devrait croître plus rapidement que le marché CN ( 14% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 688639 ( 37.9% par an) devrait croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 688639 devrait être élevé dans 3 ans ( 25.1 %)

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y